[18F]TFB PET/CT misses intense [124I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
Backhaus P, Pentlow KS, Ho AL, Mauguen A, Fagin JA, Pillarsetty NVK, Lyashchenko SK, Burnazi E, Ghossein RA, Chhabra S, Abusamra M, Larson SM, Schöder H, O'Donoghue J, Weber W, Grewal RK.
Backhaus P, et al. Among authors: larson sm.
EJNMMI Res. 2024 Oct 8;14(1):91. doi: 10.1186/s13550-024-01138-x.
EJNMMI Res. 2024.
PMID: 39377970
Free PMC article.